Health Economics Review

2011 - 2022

Current editor(s): J. Matthias Graf von der Schulenburg

From Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Track citations for all items by RSS feed
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 12, issue 1, 2022

The comparison of catastrophic health expenditure and its inequality between urban and rural households in China pp. 1-17

Xian-zhi Fu

The healthcare inequality among middle-aged and older adults in China: a comparative analysis between the full samples and the homogeneous population pp. 1-17

Liping Fu, Ya’nan Fang and Yongqing Dong

Grey systems in the management of demand for palliative care services in Poland pp. 1-13

Sylwia Nieszporska

Efficiency and management factors: finding the balance in Thalassaemia care centres pp. 1-13

Asrul Akmal Shafie, Noor Syahireen Mohammed, Kok Fong See, Hishamshah Mohd Ibrahim, Jacqueline Hui Yi Wong and Irwinder Kaur Chhabra

Economic impact of powered stapler in video-assisted thoracic surgery lobectomy for lung Cancer in a Chinese tertiary hospital: a cost-minimization analysis pp. 1-13

Yang Cao, Fang Xiong, Xiaozhe Xia, Pengjuan Gu, Qinghong Wang, Aiping Wu, Huan Zhan, Wendong Chen and Zhaoxin Qian

Cost-effectiveness of a photopethysmographic procedure for screening for atrial fibrillation in 6 European countries pp. 1-13

Steffen Wahler, Ralf Birkemeyer, Dimitrios Alexopoulos, Zbigniew Siudak, Alfred Müller and Johann-Matthias Schulenburg

Health economic evaluation of digital nursing technologies: a review of methodological recommendations pp. 1-13

Kai Huter, Tobias Krick and Heinz Rothgang

Harmonization issues in unit costing of service use for multi-country, multi-sectoral health economic evaluations: a scoping review pp. 1-13

Claudia Fischer, Susanne Mayer, Nataša Perić and Judit Simon

Economic burden of multiple sclerosis: a cross-sectional study in Iran pp. 1-10

Mehdi Rezaee, Khosro Keshavarz, Sadegh Izadi, Abdosaleh Jafari and Ramin Ravangard

The economic cost of implementing antigen-based rapid diagnostic tests for COVID-19 screening in high-risk transmission settings: evidence from Germany pp. 1-10

Alfonso Valenzuela Hurtado, Hoa Thi Nguyen, Viktoria Schenkel, Jonas Wachinger, Joachim Seybold, Claudia M. Denkinger and Manuela Allegri

Innovative and conventional “conservative” technologies for the treatment of uterine fibroids in Italy: a multidimensional assessment pp. 1-10

L. Ferrario, E. Garagiola, C. Gerardi, G. Bellavia, S. Colombo, C. Ticca, C. Rossetti, M. Ciboldi, M. Meroni, A. Vanzulli, A. Rampoldi, T. Bignardi, F. Arrigoni, E. Porazzi and E. Foglia

Feasibility properties of the EQ-5D-3L and 5L in the general population: evidence from the GP Patient Survey on the impact of age pp. 1-10

Ole Marten and Wolfgang Greiner

Health diplomacy to promote multisectoral participation in fighting against fragmentation and increasing budget for internalization of the health financing progress matrix in Burundi pp. 1-10

Alexandre Nimubona

Are there employment and income gains of a national breast cancer screening program? pp. 1-10

Zornitza Kambourova and Adriaan Kalwij

Pooled coverage of community based health insurance scheme enrolment in Ethiopia, systematic review and meta-analysis, 2016–2020 pp. 1-10

Ahmed Tahir, Abdulahi Omer Abdilahi and Abdifatah Elmi Farah

Epidemics, pandemics and income inequality pp. 1-15

Chrys Esseau-Thomas, Omar Galarraga and Sherif Khalifa

COVID-19 and the efficiency of health systems in Europe pp. 1-15

Dan Lupu and Ramona Tiganasu

Endogenous health risks, poverty traps, and the roles of health insurance in poverty alleviation pp. 1-15

Pu Liao, Xun Zhang and Wanlu Zhang

How much do government and households spend on an episode of hospitalisation in India? A comparison for public and private hospitals in Chhattisgarh state pp. 1-15

Samir Garg, Narayan Tripathi, Alok Ranjan and Kirtti Kumar Bebarta

An equity analysis on the household costs of accessing and utilising maternal and child health care services in Tanzania pp. 1-15

Peter Binyaruka and Josephine Borghi

Quality of life and cost consequence of delays in endovascular treatment for acute ischemic stroke in China pp. 1-8

Weiyi Ni, Wolfgang G. Kunz, Mayank Goyal, Lijin Chen and Yawen Jiang

Health insurance coverage in Ethiopia: financial protection in the Era of sustainable development goals (SDGs) pp. 1-7

Bedasa Taye Merga, Bikila Balis, Habtamu Bekele and Gelana Fekadu

Examining proximity to death and health care expenditure by disease: a Bayesian-based descriptive statistical analysis from the National Health Insurance database in Japan pp. 1-19

Yuji Hiramatsu, Hiroo Ide, Atsuko Tsuchiya and Yuji Furui

Comparative study of the effect of National Health Insurance Scheme on use of delivery and antenatal care services between rural and urban women in Ghana pp. 1-19

Raymond Elikplim Kofinti, Emmanuel Ekow Asmah and Edward Kwabena Ameyaw

How innovation can be defined, evaluated and rewarded in health technology assessment pp. 1-11

Juan Carlos Rejon-Parrilla, Jaime Espin and David Epstein

Forgone healthcare and financial burden due to out-of-pocket payments in Bangladesh: a multilevel analysis pp. 1-11

Md. Mizanur Rahman, Md. Rashedul Islam, Md. Shafiur Rahman, Fahima Hossain, Ashraful Alam, Md. Obaidur Rahman, Jenny Jung and Shamima Akter

Explaining external economic support inequality among households affected by HIV/AIDS in Tanzania: an Oaxaca Blinder decomposition analysis pp. 1-11

Wilfried Guets, Edward Kwabena Ameyaw and Sanni Yaya

Structural changes in the Russian health care system: do they match European trends? pp. 1-11

Sergey Shishkin, Igor Sheiman, Vasily Vlassov, Elena Potapchik and Svetlana Sazhina

Pancreatic stone protein point-of-care testing can reduce healthcare expenditure in sepsis pp. 1-11

John E. Schneider, Katherine Dick, Jacie T. Cooper and Nadine Chami

Hospital unit costs in Jordan: insights from a country facing competing health demands and striving for universal health coverage pp. 1-9

Eman A. Hammad, Ibrahim Alabbadi, Fardos Taissir, Malek Hajjwi, Nathir M. Obeidat, Qais Alefan and Rimal Mousa

Evaluating a capacity development intervention in health economics among producers and users of evidence in Nigeria: a case study in Getting Research Into Policy and Practice (GRIPP) in Anambra State pp. 1-9

Charles C. Ezenduka and Obinna E. Onwujekwe

Sociodemographic and health factors associated with the risk of financial catastrophe when informal care for patients with haematological neoplasms is replaced by formal care pp. 1-12

Raúl Pozo-Rubio and Marta Ortega-Ortega

How can a joint European health technology assessment provide an ‘additional benefit’ over the current standard of national assessments? pp. 1-12

Elaine Julian, Fabrizio Gianfrate, Oriol Sola-Morales, Peter Mol, Jean-François Bergmann, Tomas Salmonson, Ansgar Hebborn, Mathilde Grande and Jörg Ruof

Trajectories of prices in generic drug markets: what can we infer from looking at trajectories rather than average prices? pp. 1-12

Antonio J. Trujillo, Jose C. Gutierrez, Emmanuel E. Garcia Morales, Mariana Socal, Jeromie Ballreich and Gerard Anderson

Cost of a lymphedema treatment mandate - 16 years of experience in the Commonwealth of Virginia pp. 1-12

Robert Weiss

Advancing universal health coverage in the COVID-19 era: an assessment of public health services technical efficiency and applied cost allocation in Cambodia pp. 1-20

Robert John Kolesar, Peter Bogetoft, Vanara Chea, Guido Erreygers and Sambo Pheakdey

Exploring dynamics in catastrophic health care expenditure in Nigeria pp. 1-20

Henry C. Edeh

Cardiovascular drug shortages in Lebanon: a broken heart pp. 1-2

Georges Khattar, Jennifer Hallit, Carolla El Chamieh and Elie Bou Sanayeh

Young people are medically invulnerable to COVID-19 but vulnerable in the labor market: Korean evidence pp. 1-16

Saejung Park and Joonmo Cho

A choice experiment assessment of stated early response to COVID-19 vaccines in the USA pp. 1-16

Ricardo A. Daziano

Food insecurity and health outcomes during the coronavirus pandemic in South Africa: a longitudinal study pp. 1-16

Chijioke O. Nwosu, Umakrishnan Kollamparambil and Adeola Oyenubi

An (un)healthy social dilemma: a normative messaging field experiment with flu vaccinations pp. 1-16

Irene Mussio and Angela C. M. Oliveira

Adjuvant treatment of high-risk melanoma – cost-effectiveness analysis of treatment options for BRAF 600 mutated tumors pp. 1-14

Steffen Wahler, Alfred Müller, Sabine Fuchs and Johann-Matthias Schulenburg

Volume 11, issue 1, 2021

Note from the editor, January 2021 pp. 1-2

J.-Matthias Graf Schulenburg, Sebastian Braun and Jan Zeidler

Health system efficiency in OECD countries: dynamic network DEA approach pp. 1-25

Beata Gavurova, Kristina Kocisova and Jakub Sopko

What drives different treatment choices? Investigation of hospital ownership, system membership and competition pp. 1-14

Esra Eren Bayindir and Jonas Schreyögg

Convergence in public health expenditure across the Sub-Saharan African countries: does club convergence matter? pp. 1-14

Ousmane Traoré

Decisions of persons, the pharmaceutical industry, and donors in disease contraction and recovery assuming virus mutation pp. 1-14

Kjell Hausken and Mthuli Ncube

Using the MEAT VBP Framework to analyse and understand the value of surgical gloves: an explanatory case study pp. 1-14

Benedict Stanberry, Gerhard Bothma and Katie Harrison

Practices of decision making in priority setting and resource allocation: a scoping review and narrative synthesis of existing frameworks pp. 1-11

Brayan V. Seixas, François Dionne and Craig Mitton

Economic evaluation of HIV testing options for low-prevalence high-income countries: a systematic review pp. 1-11

Olanrewaju Medu, Adegboyega Lawal, Doug Coyle and Kevin Pottie

Impact of the 2014 coinsurance rate revision for the elderly on healthcare resource utilization in Japan pp. 1-11

Takumi Nishi, Toshiki Maeda, Susumu Katsuki and Akira Babazono

Using predicted length of stay to define treatment and model costs in hospitalized adults with serious illness: an evaluation of palliative care pp. 1-11

Peter May, Charles Normand, Danielle Noreika, Nevena Skoro and J. Brian Cassel

Hospitalization budget impact during the COVID-19 pandemic in Spain pp. 1-11

F. J. Carrera-Hueso, L. Álvarez-Arroyo, J. E. Poquet-Jornet, P. Vázquez-Ferreiro, R. Martínez-Gonzalbez, D. El-Qutob, M. A. Ramón-Barrios, F. Martínez-Martínez, J. L. Poveda-Andrés and C. Crespo-Palomo

Grocery food taxes and U.S. county obesity and diabetes rates pp. 1-9

Lingxiao Wang, Yuqing Zheng, Steven Buck, Diansheng Dong and Harry M. Kaiser

Investing preventive care and economic development in ageing societies: empirical evidences from OECD countries pp. 1-9

Fuhmei Wang and Jung- Der Wang

Telemedical emergency services: central or decentral coordination? pp. 1-12

Steffen Fleßa, Rebekka Suess, Julia Kuntosch, Markus Krohn, Bibiana Metelmann, Joachim Paul Hasebrook, Peter Brinkrolf, Klaus Hahnenkamp, Dorothea Kohnen and Camilla Metelmann

Arrangements with the NHS for providing healthcare services: do they improve financial performance of private for-profit hospitals in Spain? pp. 1-12

María Victoria Ruiz-Mallorquí, Inmaculada Aguiar-Díaz and Beatriz González- López Valcárcel

Preferences of patients with asthma or COPD for treatments in pulmonary rehabilitation pp. 1-12

Kathrin Damm, Heidrun Lingner, Katharina Schmidt, Ines Aumann-Suslin, Heike Buhr-Schinner, Jochen Meyden and Konrad Schultz

Time-to-event analysis in economic evaluations: a comparison of modelling methods to assess the cost-effectiveness of transplanting a marginal quality kidney pp. 1-12

Sameera Senanayake, Nicholas Graves, Helen Healy, Keshwar Baboolal, Adrian Barnett and Sanjeewa Kularatna

Mendelian randomization: estimation of inpatient hospital costs attributable to obesity pp. 1-12

Katherine Dick, John E. Schneider, Andrew Briggs, Pascal Lecomte, Stephane A. Regnier and Michael Lean

Economic burden of lung cancer in Turkey: a cost of illness study from payer perspective pp. 1-12

Irfan Cicin, Ergun Oksuz, Nuri Karadurmus, Simten Malhan, Mahmut Gumus, Ulku Yilmaz, Levent Cansever, Halit Cinarka, Erdogan Cetinkaya, Murat Kiyik and Ahmet Ozet

Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model pp. 1-12

F. Antoñanzas, C. A. Juárez-Castelló and R. Rodríguez-Ibeas

Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review pp. 1-12

Celia Gutiérrez Villegas, María Paz-Zulueta, Manuel Herrero-Montes, Paula Parás-Bravo and María Madrazo Pérez

Effect of COVID-19 on demand for healthcare in Togo pp. 1-12

Yaovi Tossou

COVID-19 healthcare cost and length of hospital stay in Turkey: retrospective analysis from the first peak of the pandemic pp. 1-12

Ergun Oksuz, Simten Malhan, Mustafa Sait Gonen, Zekayi Kutlubay, Yilmaz Keskindemirci and Fehmi Tabak

Quality of public health insurance and individuals’ consumption structure upgrades: evidence from China pp. 1-12

Pengfei Zhang and Jinghua Gao

Development of a pharmacoeconomic registry: an example using hormonal contraceptives pp. 1-20

Annesha White, Meenakshi Srinivasan, La Marcus Wingate, Samuel Peasah and Marc Fleming

Analytical methods to assess the impacts of activity-based funding (ABF): a scoping review pp. 1-15

Gintare Valentelyte, Conor Keegan and Jan Sorensen

Multiple effects health economic evaluation of the Ahead of The Game Study for mental health promotion in sporting club communities pp. 1-15

Simon Eckermann, Nikki McCaffrey, Utsana Tonmukayakul, Christian Swann and Stewart Vella

Assessing direct healthcare costs when restricted to self-reported data: a scoping review pp. 1-15

Samira B. Jabakhanji, Jan Sorensen, Gintare Valentelyte, Lee Ann Burke, Brendan McElroy and Aileen Murphy

Which factors increase informal care hours and societal costs among caregivers of people with dementia? A systematic review of Resource Utilization in Dementia (RUD) pp. 1-15

Renira C. Angeles, Line I. Berge, Marie H. Gedde, Egil Kjerstad, Maarja Vislapuu, Nathalie G. Puaschitz and Bettina S. Husebo

Cost of provision of essential health Services in Public Health Centers of Jimma zone, Southwest Ethiopia; a provider perspective, the pointer for major area of public expenditure pp. 1-15

Diriba Feyisa, Kiddus Yitbarek and Teferi Daba

Micro-costing in health and medicine: a critical appraisal pp. 1-8

Xiao Xu, Christina M. Lazar and Jennifer Prah Ruger

Health economic evaluations comparing faecal microbiota transplantation with antibiotics for treatment of recurrent Clostridioides difficile infection: a systematic review pp. 1-8

Lianna Hede Hammeken, Simon Mark Dahl Baunwall, Christian Lodberg Hvas and Lars Holger Ehlers

The cost-utility of early use of high-flow nasal cannula in bronchiolitis pp. 1-8

Jefferson Antonio Buendía, Ranniery Acuña-Cordero and Carlos E. Rodriguez-Martinez

Financial balance of home nursing care providers in the Czech Republic pp. 1-7

Petr Fiala, Iva Holmerova, Tomas Ruda and Michal Steffl

The addition of neoadjuvant pertuzumab for the treatment of HER2+ breast cancer: a cost estimate with real-world data pp. 1-13

Andreia Borges, Filipa Pereira, Patrícia Redondo, Luís Antunes, Cláudia Vieira, Pedro Antunes, Maria José Bento, Susana Sousa, José Machado Lopes, Francisco Rocha-Gonçalves, Joaquim Abreu Sousa, Deolinda Sousa Pereira and Marina Borges

The effect of gender-specific labor market conditions on children’s weight pp. 1-13

Bongkyun Kim, Michael R. Thomsen, Rodolfo Nayga and Anthony Goudie

Supporting strategic health purchasing: a case study of annual health budgets from general tax revenue and social health insurance in Abia state, Nigeria pp. 1-13

Chinyere Mbachu, Chinyere Okeke, Chinonso Obayi, Agnes Gatome-Munyua, Nkechi Olalere, Ikechi Ogbonna, Benjamin Uzochukwu and Obinna Onwujekwe

Can adaptive clinical trials help to solve the productivity crisis of the pharmaceutical industry? - a scenario analysis pp. 1-10

Jörg Mahlich, Arne Bartol and Srirangan Dheban

“Top-down bottom-up” estimation of per capita cost of new-born care interventions in four regions of Ghana: beyond implementation to scalability and sustainability pp. 1-10

Robert Kaba Alhassan, Edward Nketiah-Amponsah, Nana A. Y. Twum-Danso, John Bawa, Williams Kwarah, Sebnem Ucer and Abdul Fatawu Abass

Can financial payments incentivize short-term smoking cessation in orthopaedic trauma patients? Evidence from a discrete choice experiment pp. 1-10

Dana Alkhoury, Jared Atchison, Antonio J. Trujillo, Kimberly Oslin, Katherine P. Frey, Robert V. O’Toole, Renan C. Castillo and Nathan N. O’Hara

Distributed education enables distributed economic impact: the economic contribution of the Northern Ontario School of Medicine to communities in Canada pp. 1-10

John C. Hogenbirk, David R. Robinson and Roger P. Strasser

Economic evaluation of process utility: elucidating preferences for a non-invasive procedure to treat restenosis pp. 1-10

Maria V. Aviles-Blanco

Distributional health and financial consequences of increased cigarette tax in Iran: extended cost-effectiveness analysis pp. 1-10

Behzad Raei, Sara Emamgholipour, Amirhossein Takian, Mehdi Yaseri, Ghahreman Abdoli and Ahad Alizadeh

Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy pp. 1-10

Francesco Saverio Mennini, Mario Gori, Ioanna Vlachaki, Francesca Fiorentino, Paola La Malfa, Duccio Urbinati and Massimo Andreoni

Out-of-pocket payments and catastrophic expenditures due to traffic injuries in Ouagadougou, Burkina Faso pp. 1-10

Laurène Petitfour, Emmanuel Bonnet, Isadora Mathevet, Aude Nikiema and Valéry Ridde

Overcoming COVID-19 in China despite shortcomings of the public health system: what can we learn? pp. 1-18

Mei Mei Wang and Steffen Fleßa

Commentary: on the effects of health expenditure on infant mortality in sub-Saharan Africa: evidence from panel data analysis pp. 1-3

Mwoya Byaro